Sumita Roy, M.D.

Hematology/Oncology

Sumita-Roy

Provider Name: Sumita Roy, M.D.

Academic Appointment: Assistant Professor

Provider Specialty: Hematology/Oncology

Areas of Clinical Focus:  Pediatric Cancer Predisposition/Benign Hematology in Primary Care/Primary Care of Children with Underlying Genetic Syndrome

Areas of Research/Scholarship Focus:  Pediatric Cancer Predisposition/Nutritional Anemia

Board Certification(s):  Pediatrics/Pediatric Hematology Oncology

Primary Practice Name:

Primary Practice Address:

City: Detroit

State: MI

ZIP Code:

Practice Phone Number:

Practice Fax:

Other Practicing Locations:

Accepted Insurance: We accept most types on insurance. Please call to confirm that your carrier is on our list.

Languages Spoken:  English/Bengali/Hindi

Medical School:  Lokmanya Tilak Municipal Medical College

Internship:  North Oakland Medical Center

Residency: Michigan State University

Fellowship: University of Michigan

Selected Publications: Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance. Clin Oncol . 2021 Sep 1;39(25):2779-2790. doi: 10.1200/JCO.20.02636. Epub 2021 May 4https://pubmed.ncbi.nlm.nih.gov/33945292/#:~:text=J%20Clin%20Oncol,Deficiency%20Undergoing%20Surveillance IMMU-18. FAVORABLE OUTCOME IN REPLICATION REPAIR DEFICIENT HYPERMUTANT BRAIN TUMORS TO IMMUNE CHECKPOINT INHIBITION: AN INTERNATIONAL RRD CONSORTIUM REGISTRY STUDY. Neuro Oncol. 2020 Dec; 22(Suppl 3): iii363. Published online 2020 Dec 4https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715575/#:~:text=PMCID%3A%20PMC7715575-,IMMU%2D18.%20FAVORABLE%20OUTCOME%20IN%20REPLICATION%20REPAIR%20DEFICIENT%20HYPERMUTANT%20BRAIN%20TUMORS%20TO%20IMMUNE%20CHECKPOINT%20INHIBITION%3A%20AN%20INTERNATIONAL%20RRD%20CONSORTIUM%20REGISTRY%20STUDY,-Eric%20Bouffet%2C1

Awards/Honors:

Share by: